Reinduction of Bevacizumab in Combination with Pegylated Liposomal Doxorubicin in a Patient with Recurrent Glioblastoma Multiforme Who Progressed on Bevacizumab/Irinotecan
Figure 1
MRI brain T1 with gadolinium
after stopping bevacizumab with irinotecan.
